Welcome to our dedicated page for METLIFE SEC filings (Ticker: MET), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on METLIFE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into METLIFE's regulatory disclosures and financial reporting.
MetLife Inc executive Shurawl Sibblies, EVP & Chief HR Officer, reported a tax-withholding disposition related to restricted stock units. On March 2, 2026, 220 shares of common stock were withheld at $73.24 per share for taxes, leaving her with 28,036 directly owned shares.
MetLife Inc. executive Marlene Debel, EVP & Chief Risk Officer, reported a tax-related share disposition. On the reported date, 4,133 shares of MetLife common stock were withheld to cover taxes on shares issued from restricted stock units. After this withholding, she directly held 154,380 shares.
MetLife Inc. President & CEO Michel Khalaf reported a tax-related share disposition tied to restricted stock units. On this Form 4, 22,420 shares of common stock were withheld at $73.24 per share to cover taxes, a non‑market transaction. After this withholding, he directly holds 697,709 shares of MetLife common stock.
MetLife executive Bill Pappas had 5,989 common shares withheld for taxes at $73.24 per share related to restricted stock units. After this tax-withholding disposition, he directly holds 83,746 common shares. He also reports indirect holdings of 10,220 shares in a 2024 GRAT and 18,750 shares in a 2025 GRAT.
MetLife Inc. executive Ramy Tadros reported a tax-related share disposition. On this Form 4, 5,166 shares of MetLife common stock were withheld on March 2, 2026 at $73.24 per share to cover taxes on shares issued from restricted stock units. After this withholding, Tadros directly holds 216,819 MetLife shares.
MetLife Inc.'s Executive Vice President and Chief Legal Officer, Monica M. Curtis, reported a tax-related share disposition on a Form 4. On March 2, 2026, 953 shares of MetLife common stock were withheld at $73.24 per share to cover taxes on shares issued from restricted stock units. After this tax-withholding disposition, she directly owned 17,646 shares of MetLife common stock.
MetLife (MET) reported proposed sales of Common Stock under a Form 144 filing. The notice lists multiple transactions dated between 12/17/2025 and 01/09/2026, with example recent sales including 562 shares on 01/09/2026 and 359 shares on 12/19/2025.
MetLife Inc. President, U.S. Business, Ramy Tadros reported stock-based compensation activity. He received 19,910 restricted stock units under a 2025 stock and incentive plan and 23,006 common shares from a 2023–2025 performance share award, deferring 80% of that payout. To cover taxes on the performance share payout, 2,299 shares were withheld at a price of $75.34 per share. After these awards and tax withholding, he directly owns 221,985 MetLife common shares.
MetLife, Inc. reported a director stock award. Non-management director Michelle Seitz acquired 273 shares of MetLife common stock on a grant basis, with a reported price of $0.00 per share.
After this award, she directly holds 273 common shares, reflecting compensation paid in stock under MetLife’s non-management director fee arrangements.
MetLife Inc. EVP & Chief Risk Officer Marlene Debel reported equity compensation transactions in company common stock. On February 24, 2026, she acquired 15,132 shares at no cost as a restricted stock unit award under MetLife’s 2025 Stock and Incentive Compensation Plan and 14,870 shares from the performance-based payout of a 2023–2025 performance share award.
On the same date, 5,624 shares at $75.34 per share were withheld to cover her tax obligations related to the performance share payout. After these transactions, she directly owned 158,513 MetLife common shares. These movements reflect stock-based compensation and related tax withholding, not open‑market buying or selling.